Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care
April 15 2024 - 7:30AM
Business Wire
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical
technology company pioneering a first-of-its-kind technology to
reduce the cost and complexity of dialysis, today announced its
partnership with the American Nephrology Nurses Association (ANNA)
as a member of its new Partnership Advisory Council. This
collaboration underscores Outset’s dedication to supporting the
nephrology nursing community and improving patient care in the
realm of kidney disease.
Leslie Trigg, Chair and CEO of Outset, shared her thoughts on
the partnership: “We enthusiastically support ANNA’s goal of
empowering and educating nephrology nurses who are essential to
delivering high-quality care to patients with kidney disease. This
partnership demonstrates our dedication to enhancing patient
outcomes and supporting the vital role of the nephrology nurses who
care for them.”
ANNA emphasized the importance of collaboration with industry
leaders to advance the nephrology nursing field. “Outset Medical’s
support, together with our other corporate partners, is important
to our mission,” said Michele Kimball, ANNA Executive Director.
“Industry participation aids in our ongoing efforts to provide
top-tier education, advocacy, and networking opportunities, all of
which helps enable our members to excel in delivering high-quality
patient care.”
As partners, Outset will strongly support ANNA’s efforts to
bring about changes that expand the role of the nephrology nurse
both as a supervisor and provider of care, foster changes that will
not only attract, but help retain more nurses in the field of
kidney patient care, and advocate for policy changes to better
support the entire kidney care workforce.
With its membership, Outset will be part of ANNA’s new
Partnership Advisory Council, providing insights and feedback on
the future of nephrology nursing. Nephrology nurses play a pivotal
role in all stages of kidney care, and the demand has grown as the
population rapidly ages. Today, more than 35 million people are
living with Chronic Kidney Disease (CKD) and more than 800,000 more
are living with kidney failure. The population living with CKD
continues to grow at the same time the field of nephrology faces a
nursing shortage. In fact, by 2030, experts project a shortage of
more than 900,000 nurses across all fields of practice. Since 2004,
there has been a 5-7% deficit in registered nurses at outpatient
dialysis facilities, and in 2018 alone there were 1,750 unfilled
nephrology jobs for RNs at just outpatient facilities, not counting
inpatient, pre-dialysis outpatient and transplant positions,
according to a 2022 study in the American Journal of Kidney
Diseases.
About the American Nephrology Nurses Association
The American Nephrology Nurses Association (ANNA) improves
members' lives through education, advocacy, networking, and
science. Since it was established as a nonprofit organization in
1969, ANNA has been serving members who span the nephrology nursing
spectrum. ANNA has a membership of 7,000 registered nurses and
other health care professionals at all levels of practice. Members
work in such areas as conservative management, peritoneal dialysis,
hemodialysis, continuous renal replacement therapies,
transplantation, industry, and government/regulatory agencies. ANNA
is committed to advancing the nephrology nursing specialty and
nurturing every ANNA member. ANNA achieves these goals by providing
the highest quality educational products, programs, and services.
Our members are leaders who advocate for patients, mentor each
other, and lobby legislators, all to inspire excellence.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a
first-of-its-kind technology to reduce the cost and complexity of
dialysis. The Tablo Hemodialysis System, FDA cleared for use from
the hospital to the home, represents a significant technological
advancement that transforms the dialysis experience for patients
and operationally simplifies it for providers. Tablo serves as a
single enterprise solution that can be utilized across the
continuum of care, allowing dialysis to be delivered anytime,
anywhere and by anyone. The integration of water purification and
on-demand dialysate production enables Tablo to serve as a dialysis
clinic on wheels, with 2-way wireless data transmission and a
proprietary data analytics platform powering a new holistic
approach to dialysis care. Tablo is a registered trademark of
Outset Medical, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240415461025/en/
Investor Contact Jim Mazzola 858-342-8272
jmazzola@outsetmedical.com
Media Contact Jennifer Sipple media@outsetmedical.com
Outset Medical (NASDAQ:OM)
Historical Stock Chart
From Apr 2024 to May 2024
Outset Medical (NASDAQ:OM)
Historical Stock Chart
From May 2023 to May 2024